Journal: iScience
Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis.
doi: 10.1016/j.isci.2023.107539
Figure Lengend Snippet: Figure 4. cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting Slt2 phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5-dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1. Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also Figure S2. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 mm nitrocellulose membrane and probing with 24 iScience 26, 107539, September 15, 2023 antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (a-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).
Techniques: Mutagenesis, Activation Assay, Western Blot, Phospho-proteomics, Inhibition, Over Expression, Clinical Proteomics, Membrane, Control